Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPERNICUS phase II neoadjuvant chemotherapy before short-course radiotherapy for rectal cancer
ISRCTN10052456Phase 2Completed
- Sponsor
- Cardiff University
- Start
- May 2012
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin and fluorouracil in rectal adenocarcinoma and colorectal cancer (CRC), sponsored by Cardiff University. Primary endpoint: Surgical resection after neoadjuvant chemotherapy. Started May 2012; status: completed.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
rectal adenocarcinomacolorectal cancer (CRC)
Beyond the preview
Go deeper on ISRCTN10052456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10052456.